García-Guerrero et al described their laboratory study where myeloma cells from 12 patients were treated with titrated doses of panobinostat (0, 10 and 25nM). In order to assess CD38 expression, the authors used flow cytometry after exposure to panobinostat. The authors then went on to assess whether an increase in CD38 expression caused by panobinostat...Continue Reading